+44 79 19 49 39 39 wilsonblaney@gmail.com

The UK’s Accelerated Access Review: Time to Dust Off Old Reports?
Members of the new partnership proposed by the AAR, including the regulator the MHRA, the health technology assessment agency NICE, and NHS England as the payer and NHS Improvement, a merger of two previous agencies concerned with regulating …
Read more on Pharmaceutical Executive (press release) (registration) (blog)


Cancer Drugs First to Take Advantage of UK Early Access Scheme
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second product under a new accelerated review process intended to make promising new drugs available to patients more quickly. The drug, Bristol Myers Squibb’s …
Read more on Regulatory Focus


Catalent (CTLT) Announces Suspension of Manufacturing at Beinheim Site
… which incorporate, as applicable, national and international regulatory and quality standards, including those of ANSM (France), the Food and Drug Administration (USA), ANVISA (Brazil), and the MHRA (UK). Catalent considers its quality standards to …
Read more on StreetInsider.com


Share Button